# WASEDA University Ventures

> WASEDA University Ventures is a VC fund backing Medical and Biotechnology. See 13 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tokyo, Japan
- Total investments: 13
- Last investment: Jun 2026
- Lead investor: 38%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/wasedavc
- Website: https://www.wasedavc.com
- Facebook: https://www.facebook.com/wasedavc

WASEDA University Ventures is a VC fund in Tokyo focused on Medical and Biotechnology. The goal of Waseda University's founding principles is to create businesses and industries that contribute to the evolution and well-being of human society and sustainability by implementing academic knowledge and research results into society through the creation and development of start-ups that use learning and "the practicalapplication of scholarship."

## Contacts

5 contacts available for WASEDA University Ventures. Shizune tracks 1 team members at WASEDA University Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/waseda-university-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.2M–$38M |
| Series A | $1.3M–$14M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 23% |
| Biotechnology | 3 | 23% |
| Information Technology | 3 | 23% |
| Commercial | 2 | 15% |
| Health Care | 2 | 15% |

23 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 6 | 46% |
| Series A | 6 | 46% |
| Convertible Note | 1 | 8% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 9 | 69% |
| United States | 1 | 8% |
| United Kingdom | 1 | 8% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Hiroaki Ohta | Representative Director, General Partner, Board Member | 4 | https://shizune.co/investors/profile/hiroaki-ohta |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Neubond | Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous assistance and therapy during daily activities, integrating rehabilitation into the patient's daily life regardless of their motor capabilities. Neubond's solutions are designed to be intuitive and effective, aiming to improve thequality of life for individuals undergoing rehabilitation. | $2M | Seed | Jun 24, 2026 |  |
| Gel-Coat Biomaterials | Gel-Coat Biomaterials is a biotechnology company that develops innovative bio-based materials and new medical technologies. | $1.3M | Series A | Apr 22, 2026 |  |
| CoreTissue BioEngineering | CoreTissue BioEngineering is a development of an artificial ligament for reconstruction of the anterior cruciate ligament in Japan. | $3.9M | Series A | Nov 10, 2025 |  |
| Tres Alchemix | Tres Alchemix is an AI-driven biotechnology company focused on accelerating drug discovery, predicting drug efficacy, and developing novel therapeutic compounds using advanced machine learning and data-driven approaches. | $4.4M | Series A | Sep 26, 2025 |  |
| Nanofiber Quantum Technologies | Nanofiber Quantum Technologies is a research and manufacturing company that develops hardware for quantum communications. Its technologies provide quantum computers using nanofibers and advanced engineering, specializing in quantum cryptography, quantum communications, and other technologies related to quantum science for social implementation. | $14M | Series A | Sep 25, 2025 |  |
| VETA | VETA strives to minimize friction caused by value differences in society through cutting-edge social science research. | $1.4M | Seed | Jun 24, 2025 |  |
| Power Diamond Systems | Power Diamond Systems is a research and development firm that focuses on diamond semiconductor devices. | $4.5M | Seed | Nov 21, 2024 |  |
| BioPhenoMA | BioPhenoMA develops an AI-powered platform for detecting ultra-trace proteins that helps accelerate new drug discovery phases. | $1.2M | Seed | Nov 07, 2024 |  |
| Quanmatic | Quanmatic is an information and technology company that provides algorithms development and solutions to bridge quantum technologies. | $3.7M | Series A | Sep 30, 2024 |  |
| Blue Laser Fusion | Blue Laser Fusion is a commercial fusion company. Blue Laser Fusion is a laser startup to commercialize laser fusion by inventing its own laser and fusion reactor. | $37.5M | Seed | Mar 06, 2024 |  |

10 of 13 investments shown.

## Co-investors
- [DNX Ventures](https://shizune.co/investors/profile/dnx-ventures) — VC Fund, 2 deals together
- [JAFCO Group](https://shizune.co/investors/profile/jafco-group) — VC Fund, 2 deals together
- [Keio Innovation Initiative](https://shizune.co/investors/profile/keio-innovations-initiative) — VC Fund, 2 deals together
- [Phoenix Venture Partners](https://shizune.co/investors/profile/phoenix-venture-partners) — VC Fund, 2 deals together
- [SPARX Group](https://shizune.co/investors/profile/sparx-group) — VC Fund, 2 deals together
- [Brevan Howard Asset Management](https://shizune.co/investors/profile/brevan-howard-asset-management) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [AME Cloud Ventures](https://shizune.co/investors/profile/ame-cloud-ventures) — VC Fund
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Japan](https://shizune.co/investors/biotechnology-investors-japan)
- [Biotechnology VC Funds in Japan](https://shizune.co/investors/biotechnology-vc-funds-japan)
- [Biotech VC Funds in Japan](https://shizune.co/investors/biotech-vc-funds-japan)
- [Manufacturing VC Funds in Japan](https://shizune.co/investors/manufacturing-vc-funds-japan)
- [Climate Investors in Japan](https://shizune.co/investors/climate-investors-japan)
- [Manufacturing Investors in Japan](https://shizune.co/investors/manufacturing-investors-japan)

## FAQ

### What does WASEDA University Ventures invest in?

WASEDA University Ventures invests primarily in Medical, Biotechnology and Information Technology startups, most often at Seed and Series A stage. Most of the 13 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is WASEDA University Ventures's check size?

WASEDA University Ventures typically joins rounds of $1.2M–$38M at Seed and $1.3M–$14M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds WASEDA University Ventures participates in.

### How do I contact WASEDA University Ventures?

Public channels for WASEDA University Ventures include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at WASEDA University Ventures?

The team at WASEDA University Ventures includes Hiroaki Ohta (Representative Director, General Partner, Board Member). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co